143 related articles for article (PubMed ID: 17963190)
21. Choosing the right anticoagulant: a critical choice when assessing pharmacokinetic parameters for tetracyclines obtained from human blood samples.
Bayliss MAJ; Kyriakides M; Rigdova K; Grier S; Lovering AM; Noel A; MacGowan A
J Antimicrob Chemother; 2019 Dec; 74(12):3643-3645. PubMed ID: 31730157
[No Abstract] [Full Text] [Related]
22. The impacts of different anticoagulants and long-term frozen storage on multiple metal concentrations in peripheral blood: a comparative study.
Bao Y; Ge X; Li L; He J; Huang S; Luo X; Chen X; Chen P; Yang X
Biometals; 2021 Oct; 34(5):1191-1205. PubMed ID: 34365581
[TBL] [Abstract][Full Text] [Related]
23. Serum and urine pharmacokinetics of tigecycline in obese class III and normal weight adults.
Pai MP
J Antimicrob Chemother; 2014 Jan; 69(1):190-9. PubMed ID: 23883872
[TBL] [Abstract][Full Text] [Related]
24. Determination of atypical nonlinear plasma−protein-binding behavior of tigecycline using an in vitro microdialysis technique.
Mukker JK; Singh RP; Derendorf H
J Pharm Sci; 2014 Mar; 103(3):1013-9. PubMed ID: 24549736
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects.
Muralidharan G; Micalizzi M; Speth J; Raible D; Troy S
Antimicrob Agents Chemother; 2005 Jan; 49(1):220-9. PubMed ID: 15616299
[TBL] [Abstract][Full Text] [Related]
26. Effect of Multi Drug Resistance Protein 4 (MRP4) Inhibition on the Pharmacokinetics and Pharmacodynamics of Ciprofloxacin in Normal and Rats with LPS-Induced Inflammation.
Prasad VG; Achanta S; Tammineni YR; Alla GR; Thirtham MR; Rao GS
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):733-741. PubMed ID: 26458556
[TBL] [Abstract][Full Text] [Related]
27. Heparin and ethylenediamine tetra-acetate as anticoagulants for fish blood.
Hattingh J
Pflugers Arch; 1975 Apr; 355(4):347-52. PubMed ID: 813183
[TBL] [Abstract][Full Text] [Related]
28. Tissue penetration and pharmacokinetics of tigecycline in diabetic patients with chronic wound infections described by using in vivo microdialysis.
Bulik CC; Wiskirchen DE; Shepard A; Sutherland CA; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2010 Dec; 54(12):5209-13. PubMed ID: 20921312
[TBL] [Abstract][Full Text] [Related]
29. Myeloperoxidase concentrations in EDTA-plasma of healthy subjects are discordant with concentrations in heparin-plasma and serum.
Scheffer PG; van der Zwan LP; Schindhelm RK; Vermue HP; Teerlink T
Clin Biochem; 2009 Sep; 42(13-14):1490-2. PubMed ID: 19524564
[TBL] [Abstract][Full Text] [Related]
30. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections.
Bookstaver PB; Williamson JC; Tucker BK; Raad II; Sherertz RJ
Ann Pharmacother; 2009 Feb; 43(2):210-9. PubMed ID: 19193593
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo activity of EDTA and antibacterial agents against the biofilm of mucoid Pseudomonas aeruginosa.
Liu Z; Lin Y; Lu Q; Li F; Yu J; Wang Z; He Y; Song C
Infection; 2017 Feb; 45(1):23-31. PubMed ID: 27189338
[TBL] [Abstract][Full Text] [Related]
32. Effects of heparin, citrate, and EDTA on plasma biochemistry of sheep: comparison with serum.
Mohri M; Rezapoor H
Res Vet Sci; 2009 Feb; 86(1):111-4. PubMed ID: 18572209
[TBL] [Abstract][Full Text] [Related]
33. Penetration of Ciprofloxacin and Amikacin into the Alveolar Epithelial Lining Fluid of Rats with Pulmonary Fibrosis.
Ni W; Yang D; Mei H; Zhao J; Liang B; Bai N; Chai D; Cui J; Wang R; Liu Y
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115351
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid penetration of tigecycline.
Pallotto C; Fiorio M; D'Avolio A; Sgrelli A; Baldelli F; Di Perri G; De Socio GV
Scand J Infect Dis; 2014 Jan; 46(1):69-72. PubMed ID: 24131423
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantification of tigecycline in rat brain tissues.
Munyeza CF; Shobo A; Baijnath S; Bratkowska D; Naiker S; Bester LA; Singh SD; Maguire GE; Kruger HG; Naicker T; Govender T
Biomed Chromatogr; 2016 Jun; 30(6):837-45. PubMed ID: 26378888
[TBL] [Abstract][Full Text] [Related]
36. Impact of Experimental Variables on the Protein Binding of Tigecycline in Human Plasma as Determined by Ultrafiltration.
Dorn C; Kratzer A; Liebchen U; Schleibinger M; Murschhauser A; Schlossmann J; Kees F; Simon P; Kees MG
J Pharm Sci; 2018 Feb; 107(2):739-744. PubMed ID: 28927988
[TBL] [Abstract][Full Text] [Related]
37. A need to revisit clinical breakpoints of tigecycline: effect of atypical non-linear plasma protein binding.
Singh RSP; Mukker JK; Drescher SK; Deitchman AN; Derendorf H
Int J Antimicrob Agents; 2017 Apr; 49(4):449-455. PubMed ID: 28237830
[TBL] [Abstract][Full Text] [Related]
38. A sensitive human bone assay for quantitation of tigecycline using LC/MS/MS.
Ji AJ; Saunders JP; Amorusi P; Wadgaonkar ND; O'Leary K; Leal M; Dukart G; Marshall B; Fluhler EN
J Pharm Biomed Anal; 2008 Nov; 48(3):866-75. PubMed ID: 18692977
[TBL] [Abstract][Full Text] [Related]
39. The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor.
De Jongh R; Vranken J; Vundelinckx G; Bosmans E; Maes M; Heylen R
Cytokine; 1997 Sep; 9(9):696-701. PubMed ID: 9325019
[TBL] [Abstract][Full Text] [Related]
40. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes.
Banfi G; Salvagno GL; Lippi G
Clin Chem Lab Med; 2007; 45(5):565-76. PubMed ID: 17484616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
